MPTP‐induced dopamine neuron degeneration and glia activation is potentiated in MDMA‐pretreated mice
Movement Disorders September 20, 2013 Giulia Costa, Lucia Frau, Jadwiga Wardas et al. 52 citations
ABSTRACT Clinical observations report a greater propensity to develop Parkinson's disease (PD) in amphetamine users. 3,4‐Methylenedioxymethamphetamine (MDMA; “ecstasy”) is an amphetamine‐related drug that is largely consumed by adolescents and young adults, which may have neuroinflammatory and neurotoxic effects. Here, the objective was to evaluate in mice whether consumption of MDMA during...